OSE Immunotherapeutics (XPAR:OSE) Short Interest


XPAR:OSE OSE Immunotherapeutics SA XPAR:OSE
53 GF Score
Price €3.05
GF Value €1.49
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is OSE Immunotherapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XPAR:OSE vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, OSE Immunotherapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSE Immunotherapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's Short Interest falls into.


XPAR:OSE
53GF Score
OSE Immunotherapeutics SA XPAR:OSE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OSE Immunotherapeutics (XPAR:OSE) Overvalued in 2026?

Based on GuruFocus' analysis, OSE Immunotherapeutics stock appears to be overvalued. The current stock price of €3.05 is trading 104.7% above its estimated GF Value™ of €1.49. GuruFocus considers OSE Immunotherapeutics to be Significantly Overvalued.

Key valuation signals for XPAR:OSE:

  • Short Interest:
  • GF Value™: €1.49 vs. price of €3.05 (104.7% above fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the XPAR:OSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OSE Immunotherapeutics Business Description

Other Exchanges ORPOF:USA0RAD:UK6OP:Germany
Address 22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
53GF Score

Get the complete analysis for XPAR:OSE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.05
Price
€1.49
GF Value